FMP
Artivion, Inc.
AORT
NYSE
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
24.12 USD
0.7 (2.9%)
2024 Q4
2024 Q3
2024 Q2
2024 Q1
97.31M
95.78M
98.02M
97.43M
35.81M
34.77M
38.65M
38.35M
61.5M
61.01M
59.37M
59.08M
58.83M
56.62M
51.11M
33.77M
7.4M
6.61M
7.5M
6.95M
51.43M
50.02M
43.61M
26.82M
0
0
2M
0
0
0
45.52M
0
0
0
-983k
-1.41M
2.67M
4.39M
8.26M
25.31M
-19.27M
-5.65M
-8.93M
-12.53M
-16.6M
-1.27M
-2.43M
12.78M
-119k
1.02M
-306k
5.25M
-16.48M
-2.29M
-2.12M
7.53M
-0.39
-0.05
-0.05
0.18
-0.39
-0.05
-0.05
0.18
41.88M
41.84M
41.68M
41.29M
41.88M
41.84M
41.68M
47.89M
-565k
13.25M
14.2M
13.77M
2024 Q4
2024 Q3
2024 Q2
2024 Q1
-44.78M
-42.49M
-40.37M
-47.91M
-16.48M
-2.29M
-2.12M
7.53M
0
83k
0
0
0
0
0
0
-61.27M
-44.78M
-42.49M
-40.37M
-16.48M
-2.21M
-2.12M
7.53M
2024 Q4
2024 Q3
2024 Q2
2024 Q1
76.13M
79.47M
79.09M
80.28M
6.29M
6.11M
5.89M
5.91M
-1.43M
-3.92M
-2.51M
-3.61M
71.26M
77.28M
75.72M
77.98M
2024 Q4
2024 Q3
2024 Q2
2024 Q1
-7.79M
4.74M
-1.02M
-2.31M
248.75M
244.01M
245.03M
247.34M
240.96M
248.75M
244.01M
245.03M
All figures are in USD.